Earlier this morning, SmallCapVoice announced that a new audio interview with International Stem Cell Corp. (internationalstemcell.com), a California-based biotechnology company, is now available. Investors who wish to listen to the 14-minute interview can access the informative dialogue at the following link: dtg.fm/cEC6.
ISCO is engaged in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The interview includes an overview of the markets being targeted by ISCO and its subsidiary companies, the goals for the companies in 2012, and the major achievements of the companies to date.
SmallCapVoice offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and company information sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets.
For additional information on ISCO, visit the company's website at InternationalStemCell.com
Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net